Intravenous Edaravone plus Therapeutic Hypothermia Offers Limited Neuroprotection in the Hypoxic-Ischaemic Newborn Piglet
Author(s) -
Satoshi Yamato,
Shinji Nakamura,
Yinmon Htun,
Makoto Nakamura,
Wataru Jinnai,
Yasuhiro Nakao,
Tsutomu Mitsuie,
Kosuke Koyano,
Takayuki Wakabayashi,
Aya Morimoto,
Masashiro Sugino,
Takashi Iwase,
Sonoko Kondo,
Saneyuki Yasuda,
Masaki Ueno,
Takanori Miki,
Takashi Kusaka
Publication year - 2020
Publication title -
neonatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.399
H-Index - 84
eISSN - 1661-7819
pISSN - 1661-7800
DOI - 10.1159/000511085
Subject(s) - hypothermia , neuroprotection , medicine , edaravone , anesthesia , ischaemic stroke , ischemia , pharmacology
Therapeutic hypothermia (TH) is a standard therapy for neonatal hypoxic-ischaemic encephalopathy. One potential additional therapy is the free radical scavenger edaravone (EV; 3-methyl-1-phenyl-2-pyrazolin-5-one).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom